American Addiction Centers Welcomes New Chief Clinical and Compliance Officer
American Addiction Centers (AAC) is pleased to announce the appointment of Tom Doub, PhD, as its new Chief Clinical and Compliance Officer. Dr. Doub brings more than 25 years of behavioral healthcare experience to his new role with a strong background in clinical best practices, research, analytics and technology.
In his new role at AAC, Dr. Doub will build upon the company’s commitment to clinical excellence and focus on improving outcomes for clients across the nation.
“I am excited to join AAC at this time when addiction is such a critical issue for this country,” said Dr. Doub. “Together, we have an opportunity to bring the best of personalized medicine to addiction treatment by bridging the gap between research and clinical practice to provide clients with proven treatment options that achieve superior outcomes.”
Dr. Doub is the former CEO of Centerstone Research Institute and Chief Clinical Officer for Centerstone, one of the nation’s largest not-for-profit providers of community-based behavioral healthcare. During his tenure at Centerstone, he led the development and implementation of clinical best practices across a multistate system, serving more than 100,000 clients per year.
Over the past decade, he has also been involved in more than 150 groundbreaking studies examining how behavioral healthcare works and helping companies improve client outcomes. More than 50 of these studies specifically addressed addiction treatment and prevention.
Dr. Doub received his PhD in both Clinical and Quantitative Psychology from Vanderbilt University.
“Dr. Doub’s proven leadership skills and research expertise are an invaluable addition to our senior management team,” said Michael Cartwright, AAC Chairman and Chief Executive Officer. “He will play an integral role in helping AAC become a national leader in providing research-based care that not only raises the bar for clinical excellence in our industry but also gives our clients the best chance for long-term recovery.”